A comparative evaluation of canine meningioma supporting the canine patient as a naturally occurring animal model for human meningioma: a report from the NCI Comparative Brain Tumor Consortium (CBTC) meningioma pathology board

Diagnostic classification criteria of canine meningioma remain poorly codified and have not been linked to outcome data in large scale studies employing standardized review of slides by a board of multiple pathologists. The National Cancer Institute-led multidisciplinary Comparative Brain Tumor Consortium (CBTC) convened a meningioma pathology board, comprising both veterinarian pathologists and physician neuropathologists, and conducted a comprehensive review of 190 cases of canine meningioma. Comparative histologic and cellular features were assessed and discussed by the board for their similarities and differences to human meningioma. All cases were morphologically classified by histologic subtypes defined by the 2016 World Health Organization (WHO) and by histologic grading system for human meningioma. The majority of canine meningiomas were classified as meningothelial (140/190); most cases (109/190) were diagnosed as grade 2, 79 as grade 1, and two cases as grade 3. The histologic features with the highest agreement between reviewers were necrosis and central nervous system (CNS) invasion (intraclass correlation (ICC) of 0.44 for both features). Although morphologic features of the human grading scheme could be applied to canine tumors, there was no statistically significant difference in outcomes between grade 1 and grade 2 tumors in our patient subset with either detailed progression and cause of death information ( n = 37) or data restricted to live/dead status ( n = 84). While similarities exist between human and canine meningioma, a revised grading framework must be utilized for canine cases, distinct from the World Health Organization classification scheme for humans. Additional studies evaluating larger numbers of similarly treated dogs are necessary, and a framework for studies to enable future meta-analysis is suggested.

Authors

Institutions

Publication Details

Journal
Veterinary oncology.
Published
2026-07-27
DOI
https://doi.org/10.1186/s44356-026-00068-1
Primary Topic
Veterinary Oncology Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A comparative evaluation of canine meningioma supporting the canine patient as a naturally occurring animal model for human meningioma: a report from the NCI Comparative Brain Tumor Consortium (CBTC) meningioma pathology board

Kaspar Matiasek, Rati Chkheidze, Molly E. Church, Jessica A. Beck et al.
Veterinary oncology.
Veterinary Oncology Research
article

A comparative evaluation of canine meningioma supporting the canine patient as a naturally occurring animal model for human meningioma: a report from the NCI Comparative Brain Tumor Consortium (CBTC) meningioma pathology board

Kaspar Matiasek, Rati Chkheidze, Molly E. Church, Jessica A. Beck, Joanna J. Phillips, Sara Belluco, Sharika Rajan, Joanna H. Shih, Kara N. Corps, Amy LeBlanc, Andrew D. Miller, Jey W. Koehler, Daniel R. Rissi, Anat Stemmer-Rachamimov, Mirielle Bitar, Christina Mazcko, Stephen Yip
article en

Abstract

Diagnostic classification criteria of canine meningioma remain poorly codified and have not been linked to outcome data in large scale studies employing standardized review of slides by a board of multiple pathologists. The National Cancer Institute-led multidisciplinary Comparative Brain Tumor Consortium (CBTC) convened a meningioma pathology board, comprising both veterinarian pathologists and physician neuropathologists, and conducted a comprehensive review of 190 cases of canine meningioma. Comparative histologic and cellular features were assessed and discussed by the board for their similarities and differences to human meningioma. All cases were morphologically classified by histologic subtypes defined by the 2016 World Health Organization (WHO) and by histologic grading system for human meningioma. The majority of canine meningiomas were classified as meningothelial (140/190); most cases (109/190) were diagnosed as grade 2, 79 as grade 1, and two cases as grade 3. The histologic features with the highest agreement between reviewers were necrosis and central nervous system (CNS) invasion (intraclass correlation (ICC) of 0.44 for both features). Although morphologic features of the human grading scheme could be applied to canine tumors, there was no statistically significant difference in outcomes between grade 1 and grade 2 tumors in our patient subset with either detailed progression and cause of death information ( n = 37) or data restricted to live/dead status ( n = 84). While similarities exist between human and canine meningioma, a revised grading framework must be utilized for canine cases, distinct from the World Health Organization classification scheme for humans. Additional studies evaluating larger numbers of similarly treated dogs are necessary, and a framework for studies to enable future meta-analysis is suggested.

Veterinary oncology.Vol. 3(1)
Université Claude Bernard Lyon 1 (FR), National Institutes of Health (US), Nationwide Children's Hospital (US), Harvard University (US), University of British Columbia (CA), University of Georgia (US), University of California, San Francisco (US), Cornell University (US), University of Alabama at Birmingham (US), Massachusetts General Hospital (US), Office of the Director (US), VetAgro Sup (FR), National Cancer Institute (US), Center for Cancer Research (US), New York State College of Veterinary Medicine (US), Neurological Surgery (US), The Ohio State University (US), University of Pennsylvania (US), Ludwig-Maximilians-Universität München (DE), Auburn University (US), The University of Texas Southwestern Medical Center (US)
U.S. Department of Health and Human Services, American Kennel Club Canine Health Foundation, National Institutes of Health, National Cancer Institute
Good health and well-being
Openalex Percentile: Top 10%
Veterinary Oncology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.